Acrivon ipo price
WebNov 15, 2024 · Acrivon priced 7.5M shares at $12.50, raising around $94M. Underwriters were given a 30-day option to buy up to 1.13M additional shares at the IPO price. WebWatertown, Massachusetts-based Acrivon sold 7.55 million shares at $12.50 each, raising $94.4 million, well below its forecasted price range of $16 to $18. Acrivon bolstered the size of its...
Acrivon ipo price
Did you know?
WebNov 3, 2024 · Acrivon's IPO Details ACRV intends to sell 5.9 million shares of common stock at a proposed midpoint price of $17.00 per share for gross proceeds of … WebAcrivon Therapeutics secures $100M to give Eli Lilly cancer drug another try, fund 2 solid tumor candidates Boston Business Journal 11. 11. 2024 With $100M, startup to bring Lilly-licensed drug into trials Precision Oncology News 11. 11. 2024 Acrivon Therapeutics Raises $100M in Series B Funding See more
WebApr 10, 2024 · Acrivon Therapeutics Inc. on Thursday set an estimated price range of $16 to $18 a share in its upcoming initial public offering (IPO) on the Nasdaq under the … Web$8.79 (As of Thursday Closing) General Information Description Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Company matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform.
WebPart of founding team of Kiniksa Pharmaceuticals and led company through IPO and product launch; Expanded portfolio of Synageva BioPharma as Group VP and General Manager, … WebApr 12, 2024 · According to analysts' consensus price target of $21.00, Acrivon Therapeutics has a forecasted upside of 138.9% from its current price of $8.79. Amount of Analyst Coverage Acrivon Therapeutics has …
WebRenaissance Capital — Oncology biotech Acrivon Therapeutics prices IPO at $12.50, well below the range Find More Contacts for Acrivon Therapeutics Peter Blume-Jensen CEO, Founder, President Executive Management 1 email found View contacts for Acrivon Therapeutics to access new leads and connect with decision-makers. View All Contacts …
WebA crivon Therapeutics (ACRV proposed), a cancer biotech aiming to raise $100.3 million, leads a life sciences-focused IPO Calendar of seven deals during this election week. This is the first big IPO ($100 million-plus) to land on the IPO Calendar since Mobileye Global, Inc. ( MBLY) scored its successful IPO in late October. pound cake made with whipping cream recipeWebNov 15, 2024 · Acrivon Therapeutics (NASDAQ: ACRV) is a clinical-stage oncology company leveraging its precision medicine platform, Acrivon Predictive Precision Proteomics (AP3), for the development of its drug pipeline. Use the CB Insights Platform to explore Acrivon Therapeutics's full profile. ... Date of IPO 11/15/2024. Market Cap 0.40B. … pound cake made with sweetened condensed milkWebOct 19, 2024 · Acrivon Therapeutics ( NASDAQ: ACRV) has filed to raise $119 million in an IPO of its common stock, according to an S-1 registration statement. The firm is a clinical … pound cake mix betty crockerWebNov 15, 2024 · After delaying its offering by a few days, the company sold 7,550,000 shares at $12.50 apiece. It also agreed to sell another 400,000 shares at the IPO price to its top … pound cake make with yellow cake mixWebNov 15, 2024 · Acrivon priced 7.5M shares at $12.50, raising around $94M. Underwriters were given a 30-day option to buy up to 1.13M additional shares at the IPO price. Jefferies, Cowen and Piper Sandler... tour of the pentagonWeb2 days ago · Since the IPO on November 15, 2024, Acrivon Therapeutics, Inc.'s market cap has decreased from $235.12M to $192.68M, a decrease of -18.05%. That is a compound … pound cake made with whipping creamWebMar 17, 2024 · The latest price target for Acrivon Therapeutics ( NASDAQ: ACRV) was reported by Cowen & Co. on Monday, December 12, 2024. The analyst firm set a price target for 0.00 expecting ACRV to fall... pound cake made with stevia recipe